| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022211 |
| Receipt No. | R000025585 |
| Official scientific title of the study | Study to see the effect of massage treatment 4 |
| Date of disclosure of the study information | 2016/05/05 |
| Last modified on | 2016/07/20 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Study to see the effect of massage treatment 4 | |
| Title of the study (Brief title) | Study of massage | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To see the effect of massage in improving cheek sagging |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluations of cheek volume, water content, elasticity, and ultrasound image before and after the repeated massage treatment for 4 days. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Apply the specific massage treatments on half cheek area for 10 minutes once a day for 4 days.
Massage cream is just applied to another cheek. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Healthy females who realize sagging on their cheeks by themselves and are concerned about them. | |||
| Key exclusion criteria | -Subjects with atopic dermatitis, eczema and pollen allergy
-Subjects who are pregnant or breast-feeding -Subjects who experienced cosmetic surgery on their faces -Subjects who had beauty medical procedures such as laser treatment, collagen injection, etc. -Subjects who visit esthetic salons on a regular basis -Subjects deemed to be inappropriate to participate in this study by the principle investigator and/or the supervising doctor |
|||
| Target sample size | 24 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshito Takahashi |
| Organization | Kao Corporation |
| Division name | R&D -Core Technology- Biological Science Research |
| Address | 5-3-28, Kotobuki-machi, Odawara-shi, Kanagawa, 250-0002, JAPAN |
| TEL | 0465-34-6116 |
| takahashi.yoshito@kao.co.jp | |
| Public contact | |
| Name of contact person | Kazue Tsukahara |
| Organization | Kao Corporation |
| Division name | R&D -Core Technology- Biological Science Research |
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN |
| TEL | 0285-68-7498 |
| Homepage URL | |
| tsukahara.kazue@kao.co.jp | |
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 花王株式会社すみだ事業所(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025585 |